Global Cannabis Applications Corp. Completes Acquisition of WasteTrakr Technologies
Vancouver, British Columbia, Canada, July 8, 2022 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), is pleased to announce that, further to its news release dated June 16, 2022, it has completed the acquisition (the “Acquisition”) of WasteTrakr Technologies, Inc. (“WTT”). The Acquisition was completed pursuant to a Share Exchange Agreement (the “Definitive Agreement”) entered into among the Company, WTT, and the shareholders of WTT (the “WTT Shareholders”). Following the completion of the Acquisition, WTT is a wholly-owned subsidiary of the Company.
Pursuant to the terms and conditions of the Definitive Agreement, the Company acquired 100% of the issued and outstanding securities of WTT in exchange for securities of the Company. Prior to the completion of the Acquisition, WTT had 10,000,000 common shares issued and outstanding (the “WTT Shares”). As consideration for the Transaction, the Company:
· issued an aggregate of 2,310,108 common shares in the capital of the Company (the “Consideration Shares”) to the WTT Shareholders pro rata in proportion to their holdings of the WTT Shares. An additional 256,692 Consideration Shares are being held back (the “Holdback Shares”) as security for the warranties, representations and covenants of WTT and the WTT Shareholders provided in the Definitive Agreement. Provided that the Company has not given notice of a claim to WTT or the WTT Shareholders, then the Holdback Shares will be issued one the date that is 180 business days following the closing of the Transaction; and · granted an aggregate of 500,000 common shares purchase warrants (the “Consideration Warrants”) to the WTT Shareholders pro rata in proportion to their holdings of the WTT Shares. Each Consideration Warrant is exercisable into one common share in the capital of the Company (a “Warrant Share”) at a price of $0.09 per Warrant Share for a period of twenty-four months from the closing of the Transaction.
The Consideration Shares and Consideration Warrants are subject to a four-month hold period.
About WTT
WasteTrakr, was funded through Tress Capital, in 2019 to pursue the lawful tracking and disposal and/or recycling of cannabis waste using specialty waste software. WTT pivoted in 2021 to focus on sustainability and how to provide recycling solutions for the waste being generated by the industry. WTT developed a LOI with a leading SoCal waste hauler to improve their waste hauling services to become a green and more sustainable eco-system.
Some former members of the WTT Management Team, including CEO and Co-Founder Steve Peterson, will lead the GCAC sales and marketing efforts, as a wholly owned subsidiary, to drive a sustainable supply chain using the GCAC blockchain product called “Efixii”. In addition, the team will be championing efforts for the cannabis, hemp and agriculture sectors to adopt ESG (Environmental, Social and Governance) practices by using the recently launched clearESG.app.
About GCAC
GCAC is a global leader in designing, developing, SaaS licensing, and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain, and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology, and acquiring high-quality cannabis datasets that improve patient outcomes and become the world’s largest cannabis efficacy data provider.
For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.